v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Millions, $ in Millions
Total
F&G
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
F&G
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-controlling Interests
Non-controlling Interests
F&G
Beginning balance (in shares) at Dec. 31, 2024     331              
Beginning balance at Dec. 31, 2024 $ 8,532   $ 0 $ 5,976   $ 5,982 $ (2,052) $ (2,152) $ 778  
Beginning balance, Treasury stock (in shares) at Dec. 31, 2024               56    
Increase (Decrease) in Stockholders' Equity                    
Exercise of stock options (in shares)     0              
Exercise of stock options 4     4            
Other comprehensive earnings - unrealized gain (loss) on investments and other financial instruments 405           405      
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates 8 [1]           8      
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation 27 [2]           27      
Reclassification adjustments for change in unrealized gains and losses included in net earnings (58) [3]           (58)      
Change in instrument-specific credit risk - market risk benefits (5) [4]           (5)      
Change in current discount rate — liability for future policy benefits (132) [5]           (132)      
Stock-based compensation 41     40         1  
Dilution from share issuance by consolidated sub       1         (1)  
Repurchases of treasury stock (in shares)               4    
Repurchases of treasury stock (186)             $ (186)    
F&G repurchases of F&G stock (10) $ 117   (7) $ 8       (3) $ 109
Dividends declared, per common share (272)         (272)        
Other comprehensive earnings associated with noncontrolling interests (42) [6]           (42)   42  
Subsidiary equity repurchases (2)               (2)  
Subsidiary dividends declared to non-controlling interests (26)               (26)  
Net earnings 376         361     15  
Ending balance (in shares) at Jun. 30, 2025     331              
Ending balance at Jun. 30, 2025 8,819   $ 0 6,022   6,071 (1,849) $ (2,338) 913  
Ending balance, Treasury stock (in shares) at Jun. 30, 2025               60    
Beginning balance (in shares) at Mar. 31, 2025     331              
Beginning balance at Mar. 31, 2025 8,797   $ 0 6,008   5,928 (1,866) $ (2,177) 904  
Beginning balance, Treasury stock (in shares) at Mar. 31, 2025               57    
Increase (Decrease) in Stockholders' Equity                    
Other comprehensive earnings - unrealized gain (loss) on investments and other financial instruments 138           138      
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates [1] 0                  
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation 21 [2]           21      
Reclassification adjustments for change in unrealized gains and losses included in net earnings (57) [3]           (57)      
Change in instrument-specific credit risk - market risk benefits (28) [4]           (28)      
Change in current discount rate — liability for future policy benefits (46) [5]           (46)      
Stock-based compensation 20     19         1  
Dilution from share issuance by consolidated sub 0     1         (1)  
Repurchases of treasury stock (in shares)               3    
Repurchases of treasury stock (161)             $ (161)    
F&G repurchases of F&G stock (9)     (6)         (3)  
Dividends declared, per common share (135)         (135)        
Other comprehensive earnings associated with noncontrolling interests (11) [6]           (11)   11  
Subsidiary dividends declared to non-controlling interests (14)               (14)  
Net earnings 293         278     15  
Ending balance (in shares) at Jun. 30, 2025     331              
Ending balance at Jun. 30, 2025 8,819   $ 0 6,022   6,071 (1,849) $ (2,338) 913  
Ending balance, Treasury stock (in shares) at Jun. 30, 2025               60    
Beginning balance (in shares) at Dec. 31, 2025     332              
Beginning balance at Dec. 31, 2025 $ 8,972   $ 0 6,042   5,484 (1,678) $ (2,424) 1,548  
Beginning balance, Treasury stock (in shares) at Dec. 31, 2025 61             61    
Increase (Decrease) in Stockholders' Equity                    
Other comprehensive earnings - unrealized gain (loss) on investments and other financial instruments $ (475)           (475)      
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates [1] 0                  
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation (27) [2]           (27)      
Reclassification adjustments for change in unrealized gains and losses included in net earnings 130 [3]           130      
Change in instrument-specific credit risk - market risk benefits 10 [4]           10      
Change in current discount rate — liability for future policy benefits 153 [5]           153      
Stock-based compensation 46     46         0  
Repurchases of treasury stock (in shares)               3    
Repurchases of treasury stock (138)             $ (138)    
F&G repurchases of F&G stock (123)     22         (145)  
Dividends declared, per common share (281)         (281)        
Additional investment in consolidated subsidiary (38)     (18)         (20)  
Other comprehensive earnings associated with noncontrolling interests 54 [6]           54   (54)  
Change in F&G outside tax basis 22     (4)     26      
Subsidiary dividends declared to non-controlling interests (39)               (39)  
Net earnings 597         531     66  
Ending balance (in shares) at Jun. 30, 2026     332              
Ending balance at Jun. 30, 2026 $ 8,809   $ 0 6,088   5,734 (1,807) $ (2,562) 1,356  
Ending balance, Treasury stock (in shares) at Jun. 30, 2026 64             64    
Beginning balance (in shares) at Mar. 31, 2026     332              
Beginning balance at Mar. 31, 2026 $ 8,719   $ 0 6,068   5,586 (1,895) $ (2,505) 1,465  
Beginning balance, Treasury stock (in shares) at Mar. 31, 2026               63    
Increase (Decrease) in Stockholders' Equity                    
Other comprehensive earnings - unrealized gain (loss) on investments and other financial instruments 116           116      
Other comprehensive earnings - unrealized gain on investments in unconsolidated affiliates [1] 0                  
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation (15) [2]           (15)      
Reclassification adjustments for change in unrealized gains and losses included in net earnings 105 [3]           105      
Change in instrument-specific credit risk - market risk benefits (28) [4]           (28)      
Change in current discount rate — liability for future policy benefits (9) [5]           (9)      
Stock-based compensation 24     26         (2)  
Repurchases of treasury stock (in shares)               1    
Repurchases of treasury stock (57)             $ (57)    
F&G repurchases of F&G stock (94)     13         (107)  
Dividends declared, per common share (140)         (140)        
Additional investment in consolidated subsidiary (38)     (18)         (20)  
Other comprehensive earnings associated with noncontrolling interests (51) [6]           (51)   51  
Change in F&G outside tax basis (31)     (1)     (30)      
Subsidiary dividends declared to non-controlling interests (19)               (19)  
Net earnings 276         288     (12)  
Ending balance (in shares) at Jun. 30, 2026     332              
Ending balance at Jun. 30, 2026 $ 8,809   $ 0 $ 6,088   $ 5,734 $ (1,807) $ (2,562) $ 1,356  
Ending balance, Treasury stock (in shares) at Jun. 30, 2026 64             64    
[1] Net of income tax expense of $2 million for the six months ended June 30, 2025.
[2] Net of income tax (benefit) expense of $(4) million and $6 million for the three months ended June 30, 2026 and 2025, respectively, and $(8) million and $7 million for the six months ended June 30, 2026 and 2025, respectively.
[3] Net of income tax expense (benefit) of $28 million and $(16) million for the three months ended June 30, 2026 and 2025, respectively, and $35 million and $(16) million for the six months ended June 30, 2026 and 2025, respectively.
[4] Net of income tax (benefit) expense of $(7) million and $(8) million for the three months ended June 30, 2026 and 2025, respectively, and $3 million and $(2) million for the six months ended June 30, 2026 and 2025, respectively.
[5] Net of income tax (benefit) expense of $(2) million and $(14) million for the three months ended June 30, 2026 and 2025, respectively, and $41 million and $(35) million for the six months ended June 30, 2026 and 2025, respectively.
[6] Net of income tax (benefit) expense of $(14) million and $(3) million for the three months ended June 30, 2026 and 2025, respectively, and $14 million and $(11) million for the six months ended June 30, 2026, and 2025, respectively.